The third quarter of 2022 saw a 40% drop in global health innovation funding from the previous quarter, continuing a year-long trend of market contraction, StartUp Health reports. Is this a new normal for the health sector or just investors reacting temporarily to macro market forces? Much depends on your mindset — and your destination. One thing is certain: there’s still a massive need and desire to achieve audacious health moonshots.
While total funding has dipped, median deal size has stayed high. So far this year median deal size has been $14.5M compared to $16M in 2021 and $10M in 2020. Read more.
